GlobalData on MSN

GSK forges pact with Empirico for respiratory siRNA in $745m deal

GSK now has the global development and commercialisation rights to the COPD-targeting oligonucleotide, EMP-012.
Healio

GLP-1 receptor agonist use linked to fewer exacerbations for patients with asthma, obesity

Patients with obesity and asthma who used GLP-1 receptor agonists had significantly fewer exacerbations and prednisone use ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript October 28, 2025 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS ...

Lower eosinophil count linked to mortality in patients with acute COPD exacerbation in ICU

For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to the intensive care unit ...

GSK plc (GSK) Q3 2025 Earnings Call Transcript

GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...